Agios Pharmaceuticals | AGIO - ايرادات المبيعات





مبيعات تغيير تاريخ
AbbVie USD 16.99B 1.99B 2026-06
Agios Pharmaceuticals USD 44.74M 25.94M 2026-06
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
Amgen USD 8.62B 1.28B 2026-03
Arrowhead Research USD 73.74M 190.29M 2026-03
Astellas Pharma JPY 537.93B 33.28B 2026-03
AstraZeneca USD 15.38B 90M 2026-06
Bayer EUR 13.41B 1.97B 2026-03
Biogen USD 2.74B 490M 2026-06
BioMarin Pharmaceutical USD 766M 109M 2026-03
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Daiichi Sankyo JPY 574.74B 12.26B 2026-06
Eli Lilly USD 19.8B 500M 2026-03
Exelixis USD 610.8M 12.14M 2026-03
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 8.41B 781M 2026-06
Incyte USD 1.67B 400M 2026-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
Merck USD 16.29B 110M 2026-03
Moderna USD 100M 289M 2026-06
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Novartis USD 14.41B 1.3B 2026-06
Novartis USD 13.11B 750M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Vertex Pharmaceuticals USD 2.99B 200M 2026-03